Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Serra-Burriel
Pcv51 - Cost Analysis of Safety Outcomes of Dabigatran vs. Warfarin in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Dabigatran Compared With Rivaroxaban vs Warfarin
JAMA Internal Medicine
Internal Medicine
Cost of the National Health Service
The Lancet
Medicine
Efficacy and Safety of Dabigatran Versus Warfarin From the RE-LY Trial
Open Heart
Cardiovascular Medicine
Cardiology
The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb73 - Indirect Cost-Effectiveness Analysis of Empagliflozin Compared to Canagliflozin for Patients With T2dm and Cardiovascular Disease in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv70 - Effect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients : A Cost-Consequences Analysis of Rivaroxaban vs Warfarin for Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis
Journal of Cardiology
Cardiovascular Medicine
Cardiology
An Analysis of National Collaboration With Spanish Researchers Abroad in the Health Sciences
Health Research Policy and Systems
Medicine
Health Policy
Implementing a National Strategy for Patient Safety: Lessons From the National Health Service in England
Quality and Safety in Health Care
